Skip to main content
. Author manuscript; available in PMC: 2019 Feb 28.
Published in final edited form as: J Control Release. 2018 Jan 3;272:9–16. doi: 10.1016/j.jconrel.2017.12.032

Figure 1.

Figure 1

Schematic illustrations of nanoparticle accumulation in untreated and JO-treated tumors. (a) Perivascular nanoparticle accumulation in an untreated tumor due to the presence of tight junctions. (b) Proposed mechanism of JO binding and cleaving DSG2 and subsequent nanoparticle accumulation beyond the vasculature.